Form 4: Inari Medical Director Robert Warner Reports Share Cancellation Following Stryker Merger

Director Robert Keith Warner reports the cancellation of Inari Medical shares and restricted stock units following the merger with Stryker Corporation, with shareholders receiving $80.00 per share.

Summary

• Robert Keith Warner, a director of Inari Medical, Inc., filed a Form 4 on February 19, 2025, reporting changes in beneficial ownership.
• The filing indicates that on February 19, 2025, Inari Medical merged with Eagle 1 Merger Sub, Inc., a subsidiary of Stryker Corporation, with Inari Medical surviving as a wholly-owned subsidiary of Stryker.
• As a result of the merger, each outstanding share of Inari Medical common stock was cancelled and converted into the right to receive $80.00 in cash.
• Warner's holdings of 12,149 shares of common stock and 5,190 restricted stock units (RSUs) were cancelled and converted into the right to receive cash based on the merger consideration.
• The merger was executed according to the Agreement and Plan of Merger dated January 6, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The merger provides a clear exit strategy for shareholders at a defined price. The completion of the merger removes uncertainty for Inari Medical.

Positives

• Shareholders received $80.00 per share in cash as part of the merger, providing a defined exit value.

Negatives

• The merger resulted in the cancellation of all outstanding shares of Inari Medical common stock, meaning existing shareholders no longer hold equity in the company.

Future Outlook

Inari Medical is now a wholly-owned subsidiary of Stryker Corporation, and will no longer operate as an independent publicly traded company.

Industry Context

The acquisition of Inari Medical by Stryker Corporation reflects a trend of consolidation in the medical device industry, where larger companies acquire smaller, innovative firms to expand their product portfolios and market reach.

Comparison to Industry Standards

• Mergers and acquisitions in the medical device industry often involve a premium paid to the target company's shareholders.
• The $80.00 per share paid to Inari Medical shareholders would need to be compared to other recent acquisitions in the medical device space to determine if it was a favorable deal for Inari shareholders.
• Comparable companies and projects would include other medical device firms specializing in venous disease treatment that have been acquired in recent years.

Stakeholder Impact

• Shareholders received cash for their shares.
• Employees of Inari Medical are now part of Stryker Corporation.
• The merger may lead to changes in the company's operations and strategic direction.

Key Dates

Keywords

Merger, Inari Medical, Stryker, Form 4, Beneficial Ownership, Robert Warner, Share Cancellation, RSUs, Acquisition